Search
Rifamexil
go.drugbank.com/drugs/DB20067ExperimentalRifamexil is a small molecule drug. Rifamexil has a monoisotopic molecular weight of 809.36 Da.
Categories: Heterocyclic Compounds with 4 or More RingsAcetylcholine
go.drugbank.com/drugs/DB03128ApprovedInvestigationalAcetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in … A neurotransmitter.
Synonyms: O-AcetylcholineEcopladib
go.drugbank.com/drugs/DB19921ExperimentalEcopladib has a monoisotopic molecular weight of 746.12 Da. … Ecopladib is a small molecule drug. The usage of the INN stem '-pladib' in the name indicates that Ecopladib is a phospholipase A2 inhibitor.
Categories: Phospholipase A2 InhibitorsOctreotide
go.drugbank.com/drugs/DB00104ApprovedInvestigational[L14501] Octreotide is a long-acting drug with pharmacologic activities that mimic those of the natural hormone, somatostatin, which inhibits the secretion of growth hormone. … Acromegaly is a disorder caused by excess growth hormone (GH), increasing the growth of body tissues and causing metabolic dysfunction.
Voclosporin
go.drugbank.com/drugs/DB11693ApprovedInvestigationalWithin 10 years of being diagnosed with SLE, 5-20% of those suffering from LN develop end-stage kidney disease, a fatal condition. … [A227683] Voclosporin, marketed as Lupkynis, is a calcineurin-inhibitor immunosuppressant for the treatment of LN.
LetibotulinumtoxinA
go.drugbank.com/drugs/DB16820Approved[A249920] LetibotulinumtoxinA is a type A botulinum neurotoxin produced from fermentation of _Clostridium botulinum_ strain CBFC26. … [L42330] LetibotulinumtoxinA has been a market-leading cosmetic product in South Korea for a number of years and was subsequently approved in the European Union.
Categories: Botulinum Toxins, Type ASynonyms: BoNT/A-DSSebelipase alfa
go.drugbank.com/drugs/DB11563ApprovedInvestigational[L39337] Sebelipase alfa is a recombinant form LAL approved for the treatment of LAL deficiency. … In addition, patients with LAL deficiency typically develop dyslipidemia, which itself contributes to a number of adverse cardiovascular outcomes.
Zofenopril
go.drugbank.com/drugs/DB13166ApprovedInvestigationalZofenopril is employed as both a cardioprotective and anti-hypertensive agent. It is an angiotensin-converting enzyme (ACE) inhibitor.
Categories: Agents Acting on the Renin-Angiotensin SystemViral Macrophage-Inflammatory Protein
go.drugbank.com/drugs/DB15748ExperimentalThe structure of vMIP consists of 71 residues and is a monomer under most conditions. … Viral macrophage inflammatory protein-II (vMIP) is a highly basic protein and human chemokine analog encoded by human herpesvirus-8.
Carbazochrome
go.drugbank.com/drugs/DB09012ApprovedWithdrawneither at a local or systemic level [A19744]. … It is not FDA-approved but is available as tablets or IM/SC injections in the treatment of hemorrhages in a number of countries.
International brands: Su Bo Te, Adcar AC